Literature DB >> 27528600

The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Joanne Soo-Min Kim1,2, Peter C Coyte3,2, Michelle Cotterchio4, Louise A Keogh5, Louisa B Flander6, Clara Gaff7,8, Audrey Laporte3,2.   

Abstract

BACKGROUND: This study investigated whether receiving the results of predictive genetic testing for Lynch syndrome, indicating the presence or absence of an inherited predisposition to various cancers, including colorectal cancer, was associated with change in individual colonoscopy and smoking behaviors, which could prevent colorectal cancer.
METHODS: The study population included individuals with no previous diagnosis of colorectal cancer, whose families had already identified deleterious mutations in the mismatch repair or EPCAM genes. Hypotheses were generated from a simple health economics model and tested against individual-level panel data from the Australasian Colorectal Cancer Family Registry.
RESULTS: The empirical analysis revealed evidence consistent with some of the hypotheses, with a higher likelihood of undergoing colonoscopy in those who discovered their genetic predisposition to colorectal cancer and a lower likelihood of quitting smoking in those who discovered their lack thereof.
CONCLUSIONS: Predictive genetic information about Lynch syndrome was associated with change in individual colonoscopy and smoking behaviors but not necessarily in ways to improve population health. IMPACT: The study findings suggest that the impact of personalized medicine on disease prevention is intricate, warranting further analyses to determine the net benefits and costs. Cancer Epidemiol Biomarkers Prev; 25(11); 1524-33. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27528600      PMCID: PMC5274544          DOI: 10.1158/1055-9965.EPI-16-0346

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

Review 1.  Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Authors:  A J Vickers; D G Altman
Journal:  BMJ       Date:  2001-11-10

2.  Relatives of colorectal cancer patients: factors associated with screening behavior.

Authors:  Lisa Madlensky; Mary Jane Esplen; Steven Gallinger; John R McLaughlin; Vivek Goel
Journal:  Am J Prev Med       Date:  2003-10       Impact factor: 5.043

Review 3.  Testing guidelines for hereditary non-polyposis colorectal cancer.

Authors:  Asad Umar; John I Risinger; Ernest T Hawk; J Carl Barrett
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation.

Authors:  D A Stupart; P A Goldberg; U Algar; R Ramesar
Journal:  Colorectal Dis       Date:  2009-02       Impact factor: 3.788

5.  Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome).

Authors:  Patrice Watson; Ramesh Ashwathnarayan; Henry T Lynch; Hemant K Roy
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

Review 6.  Lynch syndrome.

Authors:  Floor J Backes; David E Cohn
Journal:  Clin Obstet Gynecol       Date:  2011-06       Impact factor: 2.190

7.  Lifestyle behaviors in women with a BRCA1 or BRCA2 genetic mutation: an exploratory study guided by concepts derived from the Health Belief Model.

Authors:  Denise Spector
Journal:  Cancer Nurs       Date:  2007 Jan-Feb       Impact factor: 2.592

8.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

9.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

Review 10.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

Authors:  Theresa M Marteau; David P French; Simon J Griffin; A T Prevost; Stephen Sutton; Clare Watkinson; Sophie Attwood; Gareth J Hollands
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06
View more
  3 in total

1.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors:  Mark A Jenkins; Aung Ko Win; Allyson S Templeton; Maggie S Angelakos; Daniel D Buchanan; Michelle Cotterchio; Jane C Figueiredo; Stephen N Thibodeau; John A Baron; John D Potter; John L Hopper; Graham Casey; Steven Gallinger; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Robert W Haile
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

2.  Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.

Authors:  Bettina Meiser; Rajneesh Kaur; April Morrow; Michelle Peate; W K Tim Wong; Emily McPike; Elisa Cops; Cassandra Nichols; Rachel Austin; Miriam Fine; Letitia Thrupp; Robyn Ward; Finlay Macrae; Janet E Hiller; Alison H Trainer; Gillian Mitchell
Journal:  Hered Cancer Clin Pract       Date:  2021-04-09       Impact factor: 2.857

3.  Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients?

Authors:  Allison M Burton-Chase; Wendy M Parker; Kirsten M Donato; Shannon McCormick; Ellen R Gritz; Christopher I Amos; Karen H Lu; Patrick M Lynch; Miguel A Rodriguez-Bigas; Y Nancy You; Susan K Peterson
Journal:  J Patient Rep Outcomes       Date:  2018-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.